Diagnosis and Management of Primary Bone Tumors
Volume 1
- Publisher's listprice EUR 160.49
-
68 079 Ft (64 837 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 13 616 Ft off)
- Discounted price 54 463 Ft (51 870 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
68 079 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Springer
- Date of Publication 13 August 2025
- Number of Volumes 1 pieces, Book
- ISBN 9789819634835
- Binding Hardback
- No. of pages418 pages
- Size 254x178 mm
- Language English
- Illustrations 1 Illustrations, black & white; 229 Illustrations, color 0
Categories
Short description:
This book is the first in a two-volume set that offers comprehensive guidance on the diagnosis of bone tumors based on the WHO classification as well as management and follow-up. The emphasis throughout is on an integrated approach to diagnosis that highlights the role of clinical, radiologic, and pathologic correlation in reducing the possibility of diagnostic errors. The diagnosis of bone tumors is difficult for a variety of reasons, including various tumor subtypings, the protean radiologic manifestations, the variable pathologic findings, the presence of reactive changes, and overlapping findings between benign and malignant tumors. The author's aim is to offer the reader the best possible guidance in negotiating these difficulties. For each tumor type, a wide range of cases are presented, from the common to the very rare. Appearances on the full range of imaging studies are illustrated, including plain radiographs, bone scans, and MRI. Attention is also drawn to the role of long-term follow-up radiographs in ensuring correct diagnosis and management. This book will be an ideal resource for all practitioners and researchers involved in bone tumor diagnosis and clinical management. Volume 1 covers chondrogenic, osteogenic, fibrogenic, fibrohistiocytic, hematopoietic, osteoclastic giant cell-rich, and notochordal tumors.
MoreLong description:
This book is the first in a two-volume set that offers comprehensive guidance on the diagnosis of bone tumors based on the WHO classification as well as management and follow-up. The emphasis throughout is on an integrated approach to diagnosis that highlights the role of clinical, radiologic, and pathologic correlation in reducing the possibility of diagnostic errors. The diagnosis of bone tumors is difficult for a variety of reasons, including various tumor subtypings, the protean radiologic manifestations, the variable pathologic findings, the presence of reactive changes, and overlapping findings between benign and malignant tumors. The author's aim is to offer the reader the best possible guidance in negotiating these difficulties. For each tumor type, a wide range of cases are presented, from the common to the very rare. Appearances on the full range of imaging studies are illustrated, including conventional radiographs, bone scans, MRI, and PET CT scans. Attention is also drawn to the role of long-term follow-up radiographs in ensuring correct diagnosis and management. This book will be an ideal resource for all practitioners and researchers involved in bone tumor diagnosis and clinical management. Volume 1 covers chondrogenic, osteogenic, fibrogenic, fibrohistiocytic, hematopoietic, osteoclastic giant cell-rich, and notochordal tumors.
More
Table of Contents:
1. Chondrogenic tumors. ? A. Benign. a. Osteochondroma.- b. Chondroma ; enchondroma, periostal chondroma .- c. Subungual exostosis.- d.- Bizzare parosteal osteochondromatous proliferation.- e. Synovial chondromatosis.- B. Intermediate (Locally aggressive).- a. Chondromyxoid fibroma.- b. Atypical cartilaginous tumor/ Chondrosarcoma grade 1.- C. Intermediate (rarely metastasizing).- a. Chondroblastoma.- D. Malignant.- a. Chondrosarcoma, grade II/grade III.- b. Dedifferentiated chondrosarcoma.- c. Mesenchymal chondrosarcoma.- d. Clear cell chondrosarcoma.- 2. Osteogenic tumors.- A. Benign.- a. Osteoma.- b. Enostosis (bone island)/Osteopoikilosis.- c. Melorhesotosis.- d. Osteoid osteoma.- B. Intermediate.- a. Osteoblastoma.- C. Malignant.- a. Low-grade central osteosarcoma.- b. Conventional osteosarcoma.- c. Giant cell rich osteosarcoma .- d. Telangiectatic osteosarcoma.- e. Small cell osteosarcoma.- f. Secondary osteosarcoma.- g. Parosteal osteosarcoma.- h. Periosteal osteosarcoma.- 3.Fibrogenic tumors.- A. Intermediate (locally aggressive).- a. Desmoplastic fibroma of bone.- B. Malignant .- a. Fibrosarcoma of bone.- 4. Fibrohistiocytic tumors.- A. Benign fibrous hitiocytoma/Non-ossifying fibroma.- 5. Hematopoietic neoplasm.- A. Malignant .- a. Plasma cell myeloma.- b. Solitary plasmacytoma of bone.- c. Primary non-Hodgkin lymphoma of bone.- 6. Osteoclastic giant cell rich tumors.- A. Benign.- a. Giant cell lesion of the small bones.- B. Intermediate (locally aggressive, rarely metastasizing).- a. Giant cell tumor of bone.- C. Malignant.- a. Malignancy in giant cell tumor of bone.- 7. Notochordal tumors.- A. Benign.- a. Benign notochordal tumor.- B. Malignant.- a. Chordoma.
More
